Patient Enrollment

Mereo completes patient enrollment for brittle bone disease trial

Mereo BioPharma Group, a UK-based specialty biopharma company, has completed patient enrollment for a phase 2b clinical trial of BPS-804 (Setrusumab) for the treatment of osteogenesis imperfecta (OI).

Orano Med, RadioMedix recruit first patients in AlphaMedix phase 1 clinical trial

Orano Med and RadioMedix have recruited first three patients in the AlphaMedix phase 1 clinical trial.

Diurnal Group completes patient enrolment in Chronocort’s trial for congenital adrenal hyperplasia

Diurnal Group has completed patient enrolment in its European pivotal Phase III clinical trial of Chronocort (modified release hydrocortisone) for the treatment of congenital adrenal hyperplasia (CAH) in adults.